What Counts As Therapeutic Progress And Innovation In Longevity Biotechnology?

Longevity biotechnology is gaining interest, but experts still disagree on how to define aging. A 2024 PNAS Nexus survey showed no consensus on what aging means. Researchers Alex Zhavoronkov and Bud Mishra now propose a new framework. They said, "Clinical success can be viewed as the safe restoration of defined functions."